S&P 500   3,936.97
DOW   32,030.11
QQQ   306.12
3 Tech Stocks Well Positioned For Growth At A Reasonable Price
Penny Stock Shows Big Potential (Ad)
These 3 Dividend Growers Yield More Than the 10-Year Note
Closing prices for crude oil, gold and other commodities
Penny Stock Shows Big Potential (Ad)
GameStop Shares Surge On Surprise Profit
Want Diversified Upside in Biotechnology? Check out LABU
Penny Stock Shows Big Potential (Ad)
What is the Consumer Staples Sector?
Nike, Inc’s Q3 Surprise Isn’t All That Surprising: Is It A Buy?
S&P 500   3,936.97
DOW   32,030.11
QQQ   306.12
3 Tech Stocks Well Positioned For Growth At A Reasonable Price
Penny Stock Shows Big Potential (Ad)
These 3 Dividend Growers Yield More Than the 10-Year Note
Closing prices for crude oil, gold and other commodities
Penny Stock Shows Big Potential (Ad)
GameStop Shares Surge On Surprise Profit
Want Diversified Upside in Biotechnology? Check out LABU
Penny Stock Shows Big Potential (Ad)
What is the Consumer Staples Sector?
Nike, Inc’s Q3 Surprise Isn’t All That Surprising: Is It A Buy?
S&P 500   3,936.97
DOW   32,030.11
QQQ   306.12
3 Tech Stocks Well Positioned For Growth At A Reasonable Price
Penny Stock Shows Big Potential (Ad)
These 3 Dividend Growers Yield More Than the 10-Year Note
Closing prices for crude oil, gold and other commodities
Penny Stock Shows Big Potential (Ad)
GameStop Shares Surge On Surprise Profit
Want Diversified Upside in Biotechnology? Check out LABU
Penny Stock Shows Big Potential (Ad)
What is the Consumer Staples Sector?
Nike, Inc’s Q3 Surprise Isn’t All That Surprising: Is It A Buy?
S&P 500   3,936.97
DOW   32,030.11
QQQ   306.12
3 Tech Stocks Well Positioned For Growth At A Reasonable Price
Penny Stock Shows Big Potential (Ad)
These 3 Dividend Growers Yield More Than the 10-Year Note
Closing prices for crude oil, gold and other commodities
Penny Stock Shows Big Potential (Ad)
GameStop Shares Surge On Surprise Profit
Want Diversified Upside in Biotechnology? Check out LABU
Penny Stock Shows Big Potential (Ad)
What is the Consumer Staples Sector?
Nike, Inc’s Q3 Surprise Isn’t All That Surprising: Is It A Buy?
NYSE:NGVT

Ingevity - NGVT Stock Forecast, Price & News

$70.36
-2.05 (-2.83%)
(As of 03/22/2023 12:00 AM ET)
Add
Compare
Today's Range
$70.30
$72.70
50-Day Range
$68.89
$90.75
52-Week Range
$58.44
$90.81
Volume
140,874 shs
Average Volume
347,389 shs
Market Capitalization
$2.62 billion
P/E Ratio
12.84
Dividend Yield
N/A
Price Target
$90.67

Ingevity MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.67 Rating Score
Upside/​Downside
28.9% Upside
$90.67 Price Target
Short Interest
Bearish
2.57% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.19mentions of Ingevity in the last 14 days
Based on 7 Articles This Week
Insider Trading
Selling Shares
$1.25 M Sold Last Quarter
Proj. Earnings Growth
15.72%
From $6.36 to $7.36 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.50 out of 5 stars

Basic Materials Sector

54th out of 159 stocks

Chemicals & Allied Products Industry

8th out of 15 stocks


NGVT stock logo

About Ingevity (NYSE:NGVT) Stock

Ingevity Corp. engages in the manufacture of specialty chemicals and carbon materials. It operates through the following segments: Performance Chemicals and Performance Materials. The Performance Materials segment consists of automotive technologies and process purifications product families. Automotive technologies produces automotive carbon products used in gasoline vapor emission control systems in cars, trucks, motorcycles and boats. Process purifications produce a number of activated carbon products for food, water, beverage and chemical purification applications. The Performance Chemicals segment primarily addresses applications in three product families: pavement technologies, oilfield technologies, and industrial specialties. The company was founded on March 27, 2015 and is headquartered in North Charleston, SC.

Receive NGVT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ingevity and its competitors with MarketBeat's FREE daily newsletter.

NGVT Stock News Headlines

Penny Stock Shows Big Potential
The $4.37 trillion wellness market and the little-known penny stock to get on radar now.
Ingevity (NYSE:NGVT) Now Covered by Analysts at StockNews.com
Penny Stock Shows Big Potential
The $4.37 trillion wellness market and the little-known penny stock to get on radar now.
Ingevity (NGVT) Lags Q4 Earnings and Revenue Estimates
Ingevity reports third quarter 2022 financial results
Here's Why Ingevity (NGVT) is a Strong Growth Stock
See More Headlines
Receive NGVT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ingevity and its competitors with MarketBeat's FREE daily newsletter.

NGVT Company Calendar

Last Earnings
2/27/2023
Today
3/23/2023
Next Earnings (Estimated)
5/03/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Chemicals & allied products
Sub-Industry
N/A
Previous Symbol
NASDAQ:NGVT
Employees
2,050
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$90.67
High Stock Price Forecast
$100.00
Low Stock Price Forecast
$85.00
Forecasted Upside/Downside
+28.9%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
3 Analysts

Profitability

Net Income
$211.60 million
Pretax Margin
16.16%

Debt

Sales & Book Value

Annual Sales
$1.67 billion
Cash Flow
$9.29 per share
Book Value
$18.68 per share

Miscellaneous

Free Float
36,874,000
Market Cap
$2.62 billion
Optionable
Optionable
Beta
1.83

Key Executives

  • John C. Fortson
    President, Chief Executive Officer & Director
  • Mary Dean Hall
    Chief Financial Officer & Executive Vice President
  • Stuart Edward WoodcockStuart Edward Woodcock
    Executive VP & President-Performance Materials
  • Erik Ripple
    Senior VP, Chief Growth & Innovation Officer
  • Christine Stunyo
    Chief Human Resources Officer & Senior VP













NGVT Stock - Frequently Asked Questions

Should I buy or sell Ingevity stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Ingevity in the last year. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" NGVT shares.
View NGVT analyst ratings
or view top-rated stocks.

What is Ingevity's stock price forecast for 2023?

3 brokers have issued 12-month price targets for Ingevity's shares. Their NGVT share price forecasts range from $85.00 to $100.00. On average, they anticipate the company's share price to reach $90.67 in the next twelve months. This suggests a possible upside of 28.9% from the stock's current price.
View analysts price targets for NGVT
or view top-rated stocks among Wall Street analysts.

How have NGVT shares performed in 2023?

Ingevity's stock was trading at $70.44 at the start of the year. Since then, NGVT stock has decreased by 0.1% and is now trading at $70.36.
View the best growth stocks for 2023 here
.

Are investors shorting Ingevity?

Ingevity saw a increase in short interest during the month of February. As of February 15th, there was short interest totaling 936,500 shares, an increase of 20.2% from the January 31st total of 778,800 shares. Based on an average daily trading volume, of 178,700 shares, the days-to-cover ratio is currently 5.2 days. Currently, 2.5% of the shares of the company are sold short.
View Ingevity's Short Interest
.

When is Ingevity's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 3rd 2023.
View our NGVT earnings forecast
.

How were Ingevity's earnings last quarter?

Ingevity Co. (NYSE:NGVT) released its quarterly earnings data on Monday, February, 27th. The company reported $0.57 earnings per share for the quarter, missing analysts' consensus estimates of $0.90 by $0.33. The firm earned $383.60 million during the quarter, compared to analysts' expectations of $395.77 million. Ingevity had a trailing twelve-month return on equity of 34.63% and a net margin of 12.68%. The firm's revenue for the quarter was up 14.2% compared to the same quarter last year. During the same period in the previous year, the company posted $0.78 EPS.

What guidance has Ingevity issued on next quarter's earnings?

Ingevity issued an update on its FY 2023 earnings guidance on Monday, February, 27th. The company provided EPS guidance of for the period. The company issued revenue guidance of $1.90 billion-$2.10 billion, compared to the consensus revenue estimate of $1.83 billion.

What is John Fortson's approval rating as Ingevity's CEO?

2 employees have rated Ingevity Chief Executive Officer John Fortson on Glassdoor.com. John Fortson has an approval rating of 100% among the company's employees. This puts John Fortson in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Ingevity own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Ingevity investors own include Pfizer (PFE), AbbVie (ABBV), General Electric (GE), Verizon Communications (VZ), WestRock (WRK), Abbott Laboratories (ABT), Boeing (BA), Costco Wholesale (COST), Dominion Energy (D) and Johnson & Johnson (JNJ).

What is Ingevity's stock symbol?

Ingevity trades on the New York Stock Exchange (NYSE) under the ticker symbol "NGVT."

Who are Ingevity's major shareholders?

Ingevity's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include LSV Asset Management (4.05%), Thrivent Financial for Lutherans (2.76%), Dimensional Fund Advisors LP (1.95%), Maple Rock Capital Partners Inc. (1.85%), Brown Advisory Inc. (1.82%) and Geode Capital Management LLC (1.74%). Insiders that own company stock include Erik Spencer Ripple, Phillip John Platt, Richard Allen White Jr and Stuart Edward Jr Woodcock.
View institutional ownership trends
.

How do I buy shares of Ingevity?

Shares of NGVT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Ingevity's stock price today?

One share of NGVT stock can currently be purchased for approximately $70.36.

How much money does Ingevity make?

Ingevity (NYSE:NGVT) has a market capitalization of $2.62 billion and generates $1.67 billion in revenue each year. The company earns $211.60 million in net income (profit) each year or $5.48 on an earnings per share basis.

How many employees does Ingevity have?

The company employs 2,050 workers across the globe.

How can I contact Ingevity?

Ingevity's mailing address is 4920 O`Hear Avenue Suite 400, North Charleston SC, 29406. The official website for the company is www.ingevity.com. The company can be reached via phone at (843) 740-2300, via email at daniel.gallagher@ingevity.com, or via fax at 843-740-8165.

This page (NYSE:NGVT) was last updated on 3/23/2023 by MarketBeat.com Staff